ConductScience.org, home

Paper39910018

The Efficacy of Glucagon-like Peptide-1 (GLP-1) Receptor Agonists for Insufficient Weight Loss or Regain After Metabolic/Bariatric Surgery: A Systematic Review and Meta-analysis.

Kellett J and 8 others. Obes Surg, 2025. Cited by 21 papers, by iCite.

Cite this record

ConductScience Library. The Efficacy of Glucagon-like Peptide-1 (GLP-1) Receptor Agonists for Insufficient Weight Loss or Regain After Metabolic/Bariatric Surgery: A Systematic Review and Meta-analysis. Papers, record 39910018. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/39910018

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
The Efficacy of Glucagon-like Peptide-1 (GLP-1) Receptor Agonists for Insufficient Weight Loss or Regain After Metabolic/Bariatric Surgery: A Systematic Review and Meta-analysis.
PubMed
Journal
Obes Surg
PubMed
Year
2025
PubMed
Publication types
Systematic Review, Journal Article, Meta-Analysis
PubMed
Citations, by iCite
21
iCite
Relative citation ratio, by iCite
7.01, provisional
iCite
Revised in PubMed
2026-10-10
PubMed

Authors9

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Kellett JJoseph
2Soliman SSSara S
3Podwojniak AAlicia
4Minkanic MMichelle
5Kumar GGaurav
6Goodwin BBrandon
7Yang HJHyo J
8Elsawwah JKJana K
9Nemeth ZHZoltan H

Source PubMed

Download CSV of authors

Topics7

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Weight LossMajor topic
Bariatric SurgeryMajor topic
Glucagon-Like Peptide-1 Receptor AgonistsMajor topic
Weight GainMajor topic
Obesity, MorbidMajor topic
Humans
Treatment Outcome

Source PubMed

Download CSV of topics

References35

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
136044100GLP-1 Agonist to Treat Obesity and Prevent Cardiovascular Disease: What Have We Achieved so Far?Curr Atheroscler Rep2022https://conductscience.org/library/papers/36044100PubMed
235879524The Potential of Semaglutide Once-Weekly in Patients Without Type 2 Diabetes with Weight Regain or Insufficient Weight Loss After Bariatric Surgery-a Retrospective Analysis.Obes Surg2022https://conductscience.org/library/papers/35879524PubMed
320890771Physical activity in gastric bypass patients: associations with weight loss and psychosocial functioning at 12-month follow-up.Obes Surg2011https://conductscience.org/library/papers/20890771PubMed
436926678Definition, Mechanisms and Predictors of Weight Loss Failure After Bariatric Surgery.J Metab Bariatr Surg2022https://conductscience.org/library/papers/36926678PubMed
527091444Longer-Term Physiological and Metabolic Effects of Gastric Bypass Surgery.Curr Diab Rep2016https://conductscience.org/library/papers/27091444PubMed
632656729Liraglutide Augments Weight Loss After Laparoscopic Sleeve Gastrectomy: a Randomised, Double-Blind, Placebo-Control Study.Obes Surg2021https://conductscience.org/library/papers/32656729PubMed
733555451Weight Regain and Insufficient Weight Loss After Bariatric Surgery: Definitions, Prevalence, Mechanisms, Predictors, Prevention and Management Strategies, and Knowledge Gaps-a Scoping Review.Obes Surg2021https://conductscience.org/library/papers/33555451PubMed
836765019Efficacy of the Glucagon-Like Peptide-1 Receptor Agonists Liraglutide and Semaglutide for the Treatment of Weight Regain After Bariatric surgery: a Retrospective Observational Study.Obes Surg2023https://conductscience.org/library/papers/36765019PubMed
938531038GLP-1 receptor agonists: A review of glycemic benefits and beyond.JAAPA2024https://conductscience.org/library/papers/38531038PubMed
1023645885A critical analysis of the clinical use of incretin-based therapies: Are the GLP-1 therapies safe?Diabetes Care2013https://conductscience.org/library/papers/23645885PubMed
1136752995Weight Regain After Bariatric Surgery: Scope of the Problem, Causes, Prevention, and Treatment.Curr Diab Rep2023https://conductscience.org/library/papers/36752995PubMed
1230022424Efficacy of High-Dose Liraglutide as an Adjunct for Weight Loss in Patients with Prior Bariatric Surgery.Obes Surg2018https://conductscience.org/library/papers/30022424PubMed
1329206132Effect of Grazing Behavior on Weight Regain Post-Bariatric Surgery: A Systematic Review.Nutrients2017https://conductscience.org/library/papers/29206132PubMed
1430326125Comparison of the Performance of Common Measures of Weight Regain After Bariatric Surgery for Association With Clinical Outcomes.JAMA2018https://conductscience.org/library/papers/30326125PubMed
1520152736Effect of gastric bypass surgery on the incretins.Diabetes Metab2009https://conductscience.org/library/papers/20152736PubMed
1611108273Glucagon-like peptide-1 induces cell proliferation and pancreatic-duodenum homeobox-1 expression and increases endocrine cell mass in the pancreas of old, glucose-intolerant rats.Endocrinology2000https://conductscience.org/library/papers/11108273PubMed
1725312671What is "grazing"? Reviewing its definition, frequency, clinical characteristics, and impact on bariatric surgery outcomes, and proposing a standardized definition.Surg Obes Relat Dis2014https://conductscience.org/library/papers/25312671PubMed
1821885246Food quality, physical activity, and nutritional follow-up as determinant of weight regain after Roux-en-Y gastric bypass.Nutrition2012https://conductscience.org/library/papers/21885246PubMed
1938717042Real-world persistence and adherence to glucagon-like peptide-1 receptor agonists among obese commercially insured adults without diabetes.J Manag Care Spec Pharm2024https://conductscience.org/library/papers/38717042PubMed
2037494014Safety and Efficacy of Liraglutide, 3.0 mg, Once Daily vs Placebo in Patients With Poor Weight Loss Following Metabolic Surgery: The BARI-OPTIMISE Randomized Clinical Trial.JAMA Surg2023https://conductscience.org/library/papers/37494014PubMed

See all 35 referencesDownload CSV of references

Cited by21

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 21 citations.

PMIDTitleJournalYearIn PapersSource
42861025Neuroendocrine regulation of appetite and energy balance in metabolic disorders.IBRO Neurosci Rep2026https://conductscience.org/library/papers/42861025PubMed
42802300Treatment With a GLP-1 Receptor Agonist Versus Reduction of the Gastrojejunal Anastomosis Diameter Using Endoscopic Argon Plasma Coagulation for Recurrent Weight Gain After Roux-en-Y Gastric Bypass.Obes Surg2026https://conductscience.org/library/papers/42802300PubMed
42716982Anesthetic Safety and Perioperative Outcomes in GLP-1 Receptor Agonist-Treated Patients Undergoing Lipoabdominoplasty.Aesthetic Plast Surg2026https://conductscience.org/library/papers/42716982PubMed
42174244Early Adjuvant Treatment with Semaglutide After Sleeve Gastrectomy in Patients with Class II-III Obesity: A Prospective Non-Randomized Controlled Study.Obes Surg2026https://conductscience.org/library/papers/42174244PubMed
42124786Beyond the Procedure: Revisiting the Technical Determinants of Sleeve Gastrectomy and Roux-en-Y Gastric Bypass.J Metab Bariatr Surg2026https://conductscience.org/library/papers/42124786PubMed
41998485Metabolic Outcomes and Recurrent Weight Gain 10 Years After Roux-en-Y Gastric Bypass, a Longitudinal Cohort Study.Obes Surg2026https://conductscience.org/library/papers/41998485PubMed
41954719Glucagon-Like Peptide-1 Receptor Agonists vs. Bariatric Endoscopy: A Systematic Review and Meta Analysis of Efficacy, Safety, and Metabolic Outcomes.Obes Surg2026https://conductscience.org/library/papers/41954719PubMed
41870658The effect of endoscopic transoral outlet reduction (TORe) on weight recidivism and insufficient weight loss following one-anastomosis gastric bypass (OAGB). : Tore after OAGB for weight recidivism.Langenbecks Arch Surg2026https://conductscience.org/library/papers/41870658PubMed
41799164Analysis of factors influencing weight regain after bariatric-metabolic surgery in obesity hypoventilation syndrome patients based on gastrointestinal peptide hormones.J Med Biochem2025https://conductscience.org/library/papers/41799164PubMed
41774372Long-Term Outcomes of Pouch Resizing with Ring Augmentation for Dumping Syndrome and Weight Trajectory after Roux-en-Y Gastric Bypass: A Single-Center Experience.Obes Surg2026https://conductscience.org/library/papers/41774372PubMed
41767340Nutritional Vulnerability in RYGB Unmasked by GLP-1 Therapy.ACG Case Rep J2026https://conductscience.org/library/papers/41767340PubMed
41760866Long-term outcomes of metabolic and bariatric surgery: a 10-year study of effectiveness and predictors.Int J Obes (Lond)2026https://conductscience.org/library/papers/41760866PubMed
41701436Echocardiographic evaluation and clinical implications of cardiac remodeling in obesity.J Echocardiogr2026https://conductscience.org/library/papers/41701436PubMed
41644869Optimizing Safety and Outcomes in Metabolic/Bariatric Surgery: A Conceptual Framework for Staged Minimally Invasive Treatment.Obes Surg2026https://conductscience.org/library/papers/41644869PubMed
41299124Primary Care Providers Perspectives of GLP-1 Receptor Agonists to Manage Recurrent Weight Gain after Metabolic Bariatric Surgery - a Qualitative Study.Obes Surg2026https://conductscience.org/library/papers/41299124PubMed
40877612The role of glucagon-like peptide-1 receptor agonists in weight regain treatment or prevention after bariatric surgery: a systematic review and meta-analysis.Eat Weight Disord2025https://conductscience.org/library/papers/40877612PubMed
40836203The Role of Physical Activity in Minimizing Recurrence of Weight Gain Following Metabolic and Bariatric Surgery: Current Evidence and Suggestions for Advancing Future Research.Curr Obes Rep2025https://conductscience.org/library/papers/40836203PubMed
40603775GLP-1 Agonists in Aesthetic Surgery: Implications for Perioperative Outcomes and Body Contouring Procedures.Aesthetic Plast Surg2025https://conductscience.org/library/papers/40603775PubMed
40574486Weight Cycling Deregulates Eating Behavior in Mice via the Induction of Durable Gut Dysbiosis.Adv Sci (Weinh)2025https://conductscience.org/library/papers/40574486PubMed
40208455Eating Disorders in the Context of Metabolic and Bariatric Surgery: Current Status and Future Directions.Curr Obes Rep2025https://conductscience.org/library/papers/40208455PubMed

See all 21 cited byDownload CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/39910018

GET https://conductscience.org/api/papers/v1/39910018/references?page=2